Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Regulation, Chamber Localization, and Subtype Distribution of Angiotensin II Receptors in Human Hearts

Regitz-Zagrosek, V., Friedel, N., Heymann, A., Bauer, P., Neuß, M., Rolfs, A., Steffen, C., Hildebrandt, A., Hetzer, R., Fleck, E.·1995·Circulation

Abstract

Background To assess the chamber localization, subtype distribution, and regulation of human myocardial angiotensin II receptors in heart failure, we determined the binding of angiotensin II, Sar 1 Ile 8–angiotensin II, and the subtype-specific antagonists Dup 753 (AT1-specific) and PD 123319 (AT2-specific) in atria from patients with normal (left ventricular ejection fraction >55%) or moderately impaired (left ventricular ejection fraction 30% to 55%) cardiac function and in atria and ventricles from explanted end-stage failing hearts. Sarcolemmal and combined fractions, the latter including internalized receptors, were studied. In addition, AT1 mRNA content was analyzed by polymerase chain reaction after reverse transcription. Methods and Results The number of angiotensin II binding sites (B max) in sarcolemmal fractions was significantly reduced in explanted end-stage failing hearts in comparison with control subjects and moderate heart failure (B max 3.9±0.8 versus 11.2±1.7 and 9.6±0.8 fmol/mg protein, respectively). A comparable 65% reduction in receptor numbers was found in combined fractions from end-stage failing hearts, indicating that the loss of binding sites was not due to their internalization. The dissociation constants were comparable in sarcolemmal and combined fractions and in nonfailing and failing hearts, ranging from 0.5±0.2 to 1.2±0.5 nmol/L. In nonfailing hearts, 69±4% of binding sites were blocked by the subtype-2–specific inhibitor PD 123319 and were therefore classified as AT2; 33±5% were blocked by the subtype-1–specific inhibitor DUP 753 and thus classified as subtype 1. In explanted hearts, comparable ratios of 66±5% AT2 sites and 34±5% AT1 sites were found. AT1 cDNA amplification signals by polymerase chain reaction were reduced to about one third of the level in control subjects in end-stage failing hearts. Conclusions Angiotensin II receptors in human myocardium are present in relatively low numbers, and AT2 is the predominant subtype. A significant loss of angiotensin II receptors occurs in end stage but not in moderate heart failure. The loss of receptors affects both subtypes to a comparable degree. The data suggest that the decrease in receptor density is due to a decrease in steady-state mRNA abundance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.91.5.1461

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 191

Metadata

Authors
Regitz-Zagrosek, V., Friedel, N., Heymann, A., Bauer, P., Neuß, M., Rolfs, A., Steffen, C., Hildebrandt, A., Hetzer, R., & Fleck, E.
Venue
Circulation
Published
1995-03
Volume
91
Issue
5
Pages
1461-1471
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2042601656
Cited by
191
References
1
FWCI
18.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation, Chamber Localization, and Subtype Distribution of Angiotensin II Receptors in Human Hearts. https://app.cochat.ai/papers/10.1161/01.cir.91.5.1461
The paper
Regitz-Zagrosek, V., Friedel, N., Heymann, A., Bauer, P., Neuß, M., Rolfs, A., Steffen, C., Hildebrandt, A., Hetzer, R., & Fleck, E. (1995). Regulation, Chamber Localization, and Subtype Distribution of Angiotensin II Receptors in Human Hearts. Circulation. https://doi.org/10.1161/01.cir.91.5.1461

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.